Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by <scp> IgG <sub>1</sub> </scp> Instead of <scp> IgG <sub>4</sub> </scp>

Lorenz Aglas, Line Kring Tannert, Serge A. Versteeg, Scott A. Smith, Ewa A. Bartko, Mario Wenger, Amin Kraiem, Hannah Widauer, Natália Nunes, Sibile Sinkunaite, Frank Stolz, Laurian Jongejan, Angela Neubauer, Lars H. Blom, Fatima Ferreira, Lars K. Poulsen, Carsten Bindslev‐Jensen, Ronald van Ree

Open source

DOI
10.1111/all.16606
Published
2025-06-02
Container
Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.16606,
  title = {Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by
                    <scp>
                      IgG
                      <sub>1</sub>
                    </scp>
                    Instead of
                    <scp>
                      IgG
                      <sub>4</sub>
                    </scp>},
  author = {Lorenz Aglas and Line Kring Tannert and Serge A. Versteeg and Scott A. Smith and Ewa A. Bartko and Mario Wenger and Amin Kraiem and Hannah Widauer and Natália Nunes and Sibile Sinkunaite and Frank Stolz and Laurian Jongejan and Angela Neubauer and Lars H. Blom and Fatima Ferreira and Lars K. Poulsen and Carsten Bindslev‐Jensen and Ronald van Ree},
  year = {2025},
  journal = {Allergy},
  doi = {10.1111/all.16606},
  url = {https://doi.org/10.1111/all.16606}
}

RIS

TY  - JOUR
TI  - Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by
                    <scp>
                      IgG
                      <sub>1</sub>
                    </scp>
                    Instead of
                    <scp>
                      IgG
                      <sub>4</sub>
                    </scp>
AU  - Lorenz Aglas
AU  - Line Kring Tannert
AU  - Serge A. Versteeg
AU  - Scott A. Smith
AU  - Ewa A. Bartko
AU  - Mario Wenger
AU  - Amin Kraiem
AU  - Hannah Widauer
AU  - Natália Nunes
AU  - Sibile Sinkunaite
AU  - Frank Stolz
AU  - Laurian Jongejan
AU  - Angela Neubauer
AU  - Lars H. Blom
AU  - Fatima Ferreira
AU  - Lars K. Poulsen
AU  - Carsten Bindslev‐Jensen
AU  - Ronald van Ree
PY  - 2025
JO  - Allergy
DO  - 10.1111/all.16606
UR  - https://doi.org/10.1111/all.16606
ER  - 

APA

Aglas, L., Tannert, L. K., Versteeg, S. A., Smith, S. A., Bartko, E. A., Wenger, M., Kraiem, A., Widauer, H., Nunes, N., Sinkunaite, S., Stolz, F., Jongejan, L., Neubauer, A., Blom, L. H., Ferreira, F., Poulsen, L. K., Bindslev‐Jensen, C., & Ree, R. V. (2025). Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by <scp> IgG <sub>1</sub> </scp> Instead of <scp> IgG <sub>4</sub> </scp>. Allergy. https://doi.org/10.1111/all.16606

Source records